Cargando…

Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients

Detalles Bibliográficos
Autores principales: Schimpf, Judith, Davidovic, Tamara, Abbassi-Nik, Armin, Sprenger-Mähr, Hannelore, Lhotta, Karl, Zitt, Emanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980220/
https://www.ncbi.nlm.nih.gov/pubmed/35391899
http://dx.doi.org/10.3389/ti.2022.10357
_version_ 1784681341092102144
author Schimpf, Judith
Davidovic, Tamara
Abbassi-Nik, Armin
Sprenger-Mähr, Hannelore
Lhotta, Karl
Zitt, Emanuel
author_facet Schimpf, Judith
Davidovic, Tamara
Abbassi-Nik, Armin
Sprenger-Mähr, Hannelore
Lhotta, Karl
Zitt, Emanuel
author_sort Schimpf, Judith
collection PubMed
description
format Online
Article
Text
id pubmed-8980220
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89802202022-04-06 Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients Schimpf, Judith Davidovic, Tamara Abbassi-Nik, Armin Sprenger-Mähr, Hannelore Lhotta, Karl Zitt, Emanuel Transpl Int Health Archive Frontiers Media S.A. 2022-03-22 /pmc/articles/PMC8980220/ /pubmed/35391899 http://dx.doi.org/10.3389/ti.2022.10357 Text en Copyright © 2022 Schimpf, Davidovic, Abbassi-Nik, Sprenger-Mähr, Lhotta and Zitt. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Health Archive
Schimpf, Judith
Davidovic, Tamara
Abbassi-Nik, Armin
Sprenger-Mähr, Hannelore
Lhotta, Karl
Zitt, Emanuel
Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients
title Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients
title_full Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients
title_fullStr Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients
title_full_unstemmed Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients
title_short Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients
title_sort enhanced sars-cov-2 antibody response after a third heterologous vector vaccine ad26covs1 dose in mrna vaccine-primed kidney transplant recipients
topic Health Archive
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980220/
https://www.ncbi.nlm.nih.gov/pubmed/35391899
http://dx.doi.org/10.3389/ti.2022.10357
work_keys_str_mv AT schimpfjudith enhancedsarscov2antibodyresponseafterathirdheterologousvectorvaccinead26covs1doseinmrnavaccineprimedkidneytransplantrecipients
AT davidovictamara enhancedsarscov2antibodyresponseafterathirdheterologousvectorvaccinead26covs1doseinmrnavaccineprimedkidneytransplantrecipients
AT abbassinikarmin enhancedsarscov2antibodyresponseafterathirdheterologousvectorvaccinead26covs1doseinmrnavaccineprimedkidneytransplantrecipients
AT sprengermahrhannelore enhancedsarscov2antibodyresponseafterathirdheterologousvectorvaccinead26covs1doseinmrnavaccineprimedkidneytransplantrecipients
AT lhottakarl enhancedsarscov2antibodyresponseafterathirdheterologousvectorvaccinead26covs1doseinmrnavaccineprimedkidneytransplantrecipients
AT zittemanuel enhancedsarscov2antibodyresponseafterathirdheterologousvectorvaccinead26covs1doseinmrnavaccineprimedkidneytransplantrecipients